Portfolio Company Job Board

Find a job at one of our innovative portfolio companies
Sands Capital
84
companies
5,525
Jobs
Acrivon Therapeutics
Acrivon Therapeutics
acrivon.com

Locations

Watertown, MA, USA · Cambridge, MA, USA · Cambridge, MA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2018

Acrivon Therapeutics is a clinical stage oncology company leveraging its proprietary AP3 precision medicine platform to develop targeted therapies aimed at improving patient outcomes in cancer treatment. The company focuses on matching drug mechanisms to the biological drivers of cancer, utilizing its Onco Signature companion diagnostics to identify patients who will benefit from its therapies. Acrivon's lead program, ACR-368, is a selective kinase inhibitor currently in phase 2 clinical development, demonstrating promising anti-tumor activity across various solid cancer types. With a commitment to addressing significant unmet needs in oncology, Acrivon is positioned to make a substantial impact in precision oncology through its innovative approach and advanced pipeline.

Something looks off?
Open jobs at Acrivon Therapeutics

On-site & Remote